Work

Phase I-II trial of a novel mixed haptenized autologous melanoma vaccine

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.2563

Authors: D. Berd, T. Sato, J. Kuchar, T. Riley, M. J. Mastrangelo

Institution: Thomas Jefferson University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2246666774

Cites:

Cited by: 1

Related to: 10